ES2044944T3 - Hexahidroarilquinolizinas sustituidas. - Google Patents

Hexahidroarilquinolizinas sustituidas.

Info

Publication number
ES2044944T3
ES2044944T3 ES87307541T ES87307541T ES2044944T3 ES 2044944 T3 ES2044944 T3 ES 2044944T3 ES 87307541 T ES87307541 T ES 87307541T ES 87307541 T ES87307541 T ES 87307541T ES 2044944 T3 ES2044944 T3 ES 2044944T3
Authority
ES
Spain
Prior art keywords
substituted
hexahidroarilquinolizinas
disorders
certain
hexahydroarylquinolizines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87307541T
Other languages
English (en)
Inventor
John J Baldwin
Joseph P Vacca
Joel R Huff
J Mark Wiggins
Solms S Jane De
Steven D Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2044944T3 publication Critical patent/ES2044944T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

CIERTAS HEXAHIDROARILQUINOLIZINAS SUSTITUIDAS Y SALES DE LA MISMA FARMACEUTICAMENTE ACEPTABLES SON ALFA2-ADRENOCEPTORES ANTAGONISTAS PERIFERIAMENTE SELECTIVOS. LOS COMPUESTOS SON ADAPTADOS PARA SER EMPLEADOS PARA EL TRATAMIENTO DE CIERTOS DESORDENES PATOLOGICOS, COMO HIPERTENSION, DIABETES, DESORDENES QUE ACARREAN AGREGACION DE PLAQUETAS, Y SIMILARES SIN EFECTOS LATERALES ATRIBUIDOS A UN EFECTO EN EL SISTEMA NERVIOSO CENTRAL.
ES87307541T 1986-08-28 1987-08-26 Hexahidroarilquinolizinas sustituidas. Expired - Lifetime ES2044944T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90148586A 1986-08-28 1986-08-28

Publications (1)

Publication Number Publication Date
ES2044944T3 true ES2044944T3 (es) 1994-01-16

Family

ID=25414273

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87307541T Expired - Lifetime ES2044944T3 (es) 1986-08-28 1987-08-26 Hexahidroarilquinolizinas sustituidas.

Country Status (14)

Country Link
EP (1) EP0259092B1 (es)
JP (1) JP2582799B2 (es)
KR (1) KR880002869A (es)
AT (1) ATE78482T1 (es)
AU (1) AU597412B2 (es)
CA (1) CA1288435C (es)
DE (1) DE3780542T2 (es)
DK (1) DK447387A (es)
ES (1) ES2044944T3 (es)
GR (1) GR3005537T3 (es)
IL (1) IL83586A (es)
NZ (1) NZ221485A (es)
PT (1) PT85593B (es)
ZA (1) ZA876400B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942235A (en) * 1989-03-16 1990-07-17 Merck & Co., Inc. Process for certain (2R-trans)hexahydroaroquinolizines
US5229387A (en) * 1991-09-20 1993-07-20 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US6141745A (en) * 1998-04-30 2000-10-31 Advanced Micro Devices, Inc. Functional bit identifying a prefix byte via a particular state regardless of type of instruction
FI126838B (en) 2014-12-16 2017-06-15 Vetcare Oy Process for the preparation of spirocyclic substituted benzofuroquinolizines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435573A (en) * 1973-05-25 1976-05-12 Wyeth John & Brother Ltd Indoloquinolizines
GB2106909B (en) * 1981-10-07 1984-09-19 Wyeth John & Brother Ltd Benzoquinolizines
IE57014B1 (en) * 1983-03-25 1992-03-11 Wyeth John & Brother Ltd Benzoquinolizines
IL74147A (en) * 1984-02-02 1988-08-31 Merck & Co Inc 2-acylamino-hexahydro-arylquinolizines and salts thereof and pharmaceutical compositions containing them
NZ216283A (en) * 1985-06-03 1989-10-27 Merck & Co Inc Hexahydro arylquinolizine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
JP2582799B2 (ja) 1997-02-19
JPS63139183A (ja) 1988-06-10
EP0259092B1 (en) 1992-07-22
DK447387A (da) 1988-02-29
DE3780542T2 (de) 1993-01-07
CA1288435C (en) 1991-09-03
NZ221485A (en) 1991-04-26
PT85593A (en) 1987-09-01
PT85593B (pt) 1990-05-31
ATE78482T1 (de) 1992-08-15
IL83586A (en) 1991-12-15
IL83586A0 (en) 1988-01-31
KR880002869A (ko) 1988-05-12
AU7720587A (en) 1988-03-03
ZA876400B (en) 1988-02-25
EP0259092A1 (en) 1988-03-09
GR3005537T3 (es) 1993-06-07
DK447387D0 (da) 1987-08-27
DE3780542D1 (en) 1992-08-27
AU597412B2 (en) 1990-05-31

Similar Documents

Publication Publication Date Title
FI925549A0 (fi) Nya azaheterocyklylmetyl-kromaner
ATE211743T1 (de) Substituierte 3-aminochinuclidine
ES2078440T3 (es) Compuestos farmaceuticos.
DE69017606D1 (de) Substituierte Cyclohexanole mit zentraler Nervensystemwirkung.
NO166362C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater.
ATE222763T1 (de) Verwendung von imidazo-(1,2-a)-pyridin-3-acetamid-derivaten für die therapeutische behandlung von neuropsychiatrischen syndromen in zusammenhang mit störungen der nervenbahnen der basalganglien
AU3060197A (en) Aryl substituted cyclic amines as selective dopamine d3 ligands
FI965021A0 (fi) Bentsimidatsolijohdannaisia, joilla on dopaminergistä vaikutusta keskushermostossa
NO863671L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.
ATE78482T1 (de) Substituierte hexahydroarylchinolizine.
NO924547D0 (no) Piperidylmetyl-substituerte chromanderivater
DK0431579T3 (da) Substituerede cyclohexener som midler med virkning på centralnervesystemet
NO167456C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 7-(3-amino-1-pyrrolidinyl)-8-brom-1-syklopropyl-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre
NO953892L (no) Imidazolokinoksalinon-derivater som EAA-antagonister
SE8301038L (sv) Tiopyranopyrimidinforeningar och syraadditionssalter derav
ATE187442T1 (de) Tryptamine zur behandlung von störungen der circadianen rhythmik
NO873727D0 (no) Fremgangsmaate for fremstilling av benzoxazoninforbindelser med terapeutisk aktivitet.
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
DE3483944D1 (de) Verwendung von selektiv peripheren dopamin-antagonisten zur herstellung eines arzneimittels zur topischen behandlung von okularer hypertension.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
DE3674323D1 (de) 4-methoxyisophthalsaeurederivat mit pharmakologischer wirksamkeit gegen thromboembolische erkrankung und verfahren zu dessen herstellung.
NO166447C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomt n-(1-cyclohexenylmethyl-2-pyrrolidinylmethyl)-8-ethylsulfonyl-1,5-benzodioxepan-6-carboxamid.
IT8620110A0 (it) Sistema per la regolazione dell'atina dei cestelli estraibili dei mobili, mediante angolari filettati.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 259092

Country of ref document: ES